Cargando…
The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method
Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440206/ https://www.ncbi.nlm.nih.gov/pubmed/36056033 http://dx.doi.org/10.1038/s41598-022-18869-3 |
_version_ | 1784782286304051200 |
---|---|
author | Dobrowolska Zakaria, Justyna A. Bateman, Randall J. Lysakowska, Monika Khatri, Ammaarah Jean-Gilles, Dinorah Kennedy, Matthew E. Vassar, Robert |
author_facet | Dobrowolska Zakaria, Justyna A. Bateman, Randall J. Lysakowska, Monika Khatri, Ammaarah Jean-Gilles, Dinorah Kennedy, Matthew E. Vassar, Robert |
author_sort | Dobrowolska Zakaria, Justyna A. |
collection | PubMed |
description | Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP, sAPPβ, serves as a surrogate marker of BACE1 activity in the central nervous system. This biomarker could be utilized to better understand normal APP processing, aberrant processing in the disease setting, and modulations to processing during therapeutic intervention. In this paper, we present a method for measuring the metabolism of sAPPβ and another APP proteolytic product, sAPPα, in vivo in humans using stable isotope labeling kinetics, paired with immunoprecipitation and liquid chromatography/tandem mass spectrometry. The method presented herein is robust, reproducible, and precise, and allows for the study of these analytes by taking into account their full dynamic potential as opposed to the traditional methods of absolute concentration quantitation that only provide a static view of a dynamic system. A study of in vivo cerebrospinal fluid sAPPβ and sAPPα kinetics using these methods could reveal novel insights into pathophysiological mechanisms of AD, such as increased BACE1 processing of APP. |
format | Online Article Text |
id | pubmed-9440206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94402062022-09-04 The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method Dobrowolska Zakaria, Justyna A. Bateman, Randall J. Lysakowska, Monika Khatri, Ammaarah Jean-Gilles, Dinorah Kennedy, Matthew E. Vassar, Robert Sci Rep Article Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP, sAPPβ, serves as a surrogate marker of BACE1 activity in the central nervous system. This biomarker could be utilized to better understand normal APP processing, aberrant processing in the disease setting, and modulations to processing during therapeutic intervention. In this paper, we present a method for measuring the metabolism of sAPPβ and another APP proteolytic product, sAPPα, in vivo in humans using stable isotope labeling kinetics, paired with immunoprecipitation and liquid chromatography/tandem mass spectrometry. The method presented herein is robust, reproducible, and precise, and allows for the study of these analytes by taking into account their full dynamic potential as opposed to the traditional methods of absolute concentration quantitation that only provide a static view of a dynamic system. A study of in vivo cerebrospinal fluid sAPPβ and sAPPα kinetics using these methods could reveal novel insights into pathophysiological mechanisms of AD, such as increased BACE1 processing of APP. Nature Publishing Group UK 2022-09-02 /pmc/articles/PMC9440206/ /pubmed/36056033 http://dx.doi.org/10.1038/s41598-022-18869-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Dobrowolska Zakaria, Justyna A. Bateman, Randall J. Lysakowska, Monika Khatri, Ammaarah Jean-Gilles, Dinorah Kennedy, Matthew E. Vassar, Robert The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title_full | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title_fullStr | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title_full_unstemmed | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title_short | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
title_sort | metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440206/ https://www.ncbi.nlm.nih.gov/pubmed/36056033 http://dx.doi.org/10.1038/s41598-022-18869-3 |
work_keys_str_mv | AT dobrowolskazakariajustynaa themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT batemanrandallj themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT lysakowskamonika themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT khatriammaarah themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT jeangillesdinorah themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT kennedymatthewe themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT vassarrobert themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT dobrowolskazakariajustynaa metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT batemanrandallj metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT lysakowskamonika metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT khatriammaarah metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT jeangillesdinorah metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT kennedymatthewe metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT vassarrobert metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod |